Medtronic to announce financial results for its third quarter of fiscal year 2026
Medtronic (NYSE: MDT) will report third-quarter fiscal 2026 results on Tuesday, February 17, 2026, covering the quarter ended January 23, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Medtronic (NYSE: MDT) will report third-quarter fiscal 2026 results on Tuesday, February 17, 2026, covering the quarter ended January 23, 2026.
A news release with summary financial information will be issued at ~5:45 a.m. Central Standard Time, followed by a video webcast at 7:00 a.m. CST. Replay and transcript will be posted within 24 hours.
Details
News Market Reaction – MDT
On Feb 11, the day this news came out, MDT closed 0.34% below the previous close.
Data tracked by StockTitan Argus for the Feb 11 session.
Key Figures
- Quarterly net sales
- $8,961 million
- Quarter ended October 24, 2025 (10-Q)
- Prior-year net sales
- $8,403 million
- Quarter ended October 27, 2024 (10-Q comparison)
- Quarterly net income
- $1,374 million
- Quarter ended October 24, 2025 (10-Q)
- Diluted EPS
- $1.07
- Quarter ended October 24, 2025 (vs $0.99 prior year)
- Six-month net sales
- $17,539 million
- First six months of fiscal 2026 (10-Q)
- Six-month net income
- $2,414 million
- First six months of fiscal 2026 (10-Q)
- Operating cash flow
- $2,013 million
- First six months of fiscal 2026 (10-Q)
- Dividends paid
- $1,820 million
- First six months of fiscal 2026 (10-Q)
Historical Context
-
Announced intent to acquire CathWorks to expand interventional cardiology portfolio.
-
Medicare access and new FDA clearances expanding MiniMed 780G insulin delivery options.
-
CE Mark and first U.S. IDE cases for Affera Sphere-360 PFA catheter.
-
FDA clearance for MiniMed Go smart MDI system with Abbott Instinct sensor.
-
Real-world data showing MiniMed 780G met ADA time-in-range goals on missed-bolus days.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- A news release containing summary financial information will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com
- A video webcast to discuss results will begin at 7:00 a.m. CST and can be accessed at https://investorrelations.medtronic.com
- Within 24 hours of the video webcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at https://investorrelations.medtronic.com.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts:
Justin Paquette
Public Relations
+1-612-271-7935
Ingrid Goldberg
Investor Relations
+1-763-505-2696
View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-to-announce-financial-results-for-its-third-quarter-of-fiscal-year-2026-302685523.html
SOURCE Medtronic plc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
